~
検索条件をクリア

International Journal of Myeloma 6巻 2号

発行元
日本骨髄腫学会
ISSN
ISSN(オンライン)
2187-3143
旧名・別名
抄録集:日本骨髄腫研究会総会 プログラム・抄録集

書籍情報から探す
開始頁
第41回 日本骨髄腫学会学術集会 会長挨拶
安倍正博
第41回日本骨髄腫学会学術集会 会長, 徳島大学大学院医歯薬学研究部 血液・内分泌代謝内科学
International Journal of Myeloma 6 (2) 3-3, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
EL-1 Evidence review of multiple myeloma treatment
Tadao Ishida
Department of Hematology, Japanese Red Cross Medical Center
International Journal of Myeloma 6 (2) 32-32, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
EL-2 Molecular Mechanisms Underlying Initiation and Progression of Multiple Myeloma
Yusuke Furukawa
Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University
International Journal of Myeloma 6 (2) 33-33, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
EL-3 In the age of novel therapies in multiple myeloma
Teru Hideshima
Jerome Lipper Myeloma Center Dana-Farber Cancer Institute and Harvard Medical School
International Journal of Myeloma 6 (2) 34-34, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
SY1-1 Epigenome abnormality in multiple myeloma
Hiroshi Handa
Division of Hematology, Center of Internal Medicine, Gunma University Hospital
International Journal of Myeloma 6 (2) 36-36, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
SY1-2 Exosomes promote bone marrow angiogenesis in multiple myeloma
Tomohiro Umezu1, Kazuma Ohyashiki1, Junko Ohyashiki2
1Department of Hematology, Tokyo Medical University, 2Institute of Medical Science, Tokyo Medical University
International Journal of Myeloma 6 (2) 37-37, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
SY1-3 Clinical significance of MRD measurement in patients with multiple myeloma
Kosei Matsue
Division of Hematology/Oncology. Kameda General Hospital
International Journal of Myeloma 6 (2) 38-38, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
SY2-1 Message from IMWG
Shuichi Okamoto, Eiichi Nagura
Chutoen General Medical Center, Department of Hematology
International Journal of Myeloma 6 (2) 39-39, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
SY2-1 Siginificance of imaging modality for multiple myeloma
Hiroshi Kosugi
Department of Hematology, Ogaki Municipal Hospital
International Journal of Myeloma 6 (2) 40-40, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
SY2-3 Smoldering multiple myeloma
Yasushi Takamatsu
Division of Medical Oncology, Hematology and Infectious Diseases, Department of Medicine, Fukuoka University
International Journal of Myeloma 6 (2) 41-41, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
SY3-1 Percutaneous Vertebral Augmentation (Balloon Kyphoplasty) for Multiple Myeloma
Daisuke Togawa
Department of Orthopaedic Surgery
International Journal of Myeloma 6 (2) 42-42, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
SY3-2 Monoclonal Gammopathy of Renal Significance : MGRS
Hirokazu Imai
Aichi Medical University School of Medicine, Division of Nephrology and Rheumatology
International Journal of Myeloma 6 (2) 43-43, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
SY3-3 Bone metabolism / endocrine disorders in myeloma
Takeshi Kondo, Itsuro Endo
Department of Hematology, Endocrinology & Metabolism Institute of Biomedical Sciences, Tokushima University Graduate School
International Journal of Myeloma 6 (2) 44-44, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
YSY-1 Endoplasmic reticulum stress and its targeted therapy of multiple myeloma
Masaki Ri
Department of Hematology & Oncology, Nagoya City University Graduate School of Medical Sciences
International Journal of Myeloma 6 (2) 46-46, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
YSY-2 Novel epigenetic therapies in multiple myeloma
Naoya Mimra
Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital
International Journal of Myeloma 6 (2) 47-47, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
YSY-3 The role of aberrant PDPK1 - RSK2 signaling pathway activation in multiple myeloma
Yoshiaki Chinen
Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine
International Journal of Myeloma 6 (2) 48-48, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
YSY-4 Myeloma tumor reduction and bone restoration by TAK - 1 inhibition
Jumpei Teramachi1,2
1Department of Hematology, Endocrinology and Metabolism, Tokushima University, 2Department of Histology and Oral histology, Tokushima University Graduate School
International Journal of Myeloma 6 (2) 49-49, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
YSY-5 Disease progression mediated via the immune checkpoint molecule B7 - H1 (PD - L1) in multiple myeloma
Mariko Ishibashi, Hideto Tamura, Mika Sunakawa, Koiti Inokuchi
Division of Hematology, Department of Medicine, Nippon Medical School
International Journal of Myeloma 6 (2) 50-50, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
W1-1 A multicenter retrospective collaborative study of the Japanese Society of Myeloma
Shuji Ozaki1, Takayuki Saitoh2, Hiroshi Handa3, Eiichi Nagura4, Kazuyuki Shimizu5, Hirokazu Murakami2
1Department of Hematology, Tokushima Prefectural Central Hospital, 2Department of Laboratory Sciences, Graduate School of Health Sciences, Gunma University, 3Department of Hematology, Gunma University, 4Department of Hematology, Chutoen General Medical Center, 5Department of Hematology, National East Nagoya Hospital
International Journal of Myeloma 6 (2) 52-52, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
W1-2 Multiple myeloma related diseases registry studies - KMF and JSH -
Hirohiko Shibayama
Department of Hematology and Oncology, Osaka University Graduate School of Medicine
International Journal of Myeloma 6 (2) 53-53, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
W1-3 Clinical trials conducted by JMN and IMF / AMN / JMN
Hiroshi Kosugi
Department of Hematology, Ogaki Municipal Hospital
International Journal of Myeloma 6 (2) 54-54, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
W2-1 Proteinopathy in plasma cell dyscrasia - cryoglobulinemia, crystal globulinemia and other disorders -
Akiyoshi Miwa
Department of Hematology, Natiional Center for Global Health and Medicine
International Journal of Myeloma 6 (2) 55-55, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
W2-2 Clinical significance of oligoclonal bands in patients with multiple myeloma
Manabu Fujisawa, Yasuhito Suehara, Kota Fukumoto, Kentaro Narita, Yoshiaki Usui, Masami Takeuchi, Kosei Matsue
Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center
International Journal of Myeloma 6 (2) 56-56, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
W2-3 Abdominal subcutaneous fat pad aspiration for the diagnosis of AL amyloidosis
Kanji Miyazaki
Department of Hematology, Japanese Red Cross Medical Center
International Journal of Myeloma 6 (2) 57-57, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
W2-4 Diagnostic approach for ALamyloidosis
Hiroyuki Hata
Division of Informative Clinical Sciences, Faculty of Medical Sciences, Kumamoto
International Journal of Myeloma 6 (2) 58-58, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
W2-5 Castleman disease and TAFRO syndrome
Chiaki Nakaseko
Department of Hematology, Chiba University Hospital
International Journal of Myeloma 6 (2) 59-59, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
O-1 A comparison of MRD detection among ASO - PCR, dd - PCR and NGS in pts with MM who underwent ASCT
Hiroyuki Takamatsu1, Rachel Wee1, Ryoichi Murata2, Jianbiao Zheng3, Martin Moorhead3, Naoki Takezako4, Shigeki Ito5, Toshihiro Miyamoto6, Kenji Yokoyama7, Kosei Matsue8, Tsutomu Sato9, Toshiro Kurokawa10, Hideo Yagi11, Yasushi Terasaki12, Kinya Ohata1, Takashi Yoshida13, Malek Faham3, Shinji Nakao1
1Department of Hematology, Kanazawa University, 2Division of Internal Medicine, Keiju Kanazawa Hospital, 3Adaptive Biotechnologies Corp, 4Department of Hematology, National Hospital Organization Disaster Medical Center of Japan, 5Department of Medical Oncology, Iwate Medical University School of Medicine, 6Department of Hematology/Oncology, Kyushu University Hospital, 7Department of Hematology/Oncology, Tokai University Hachioji Hospital, 8Department of Hematology/Oncology, Kameda Medical Center, 9Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, 10Department of Hematology, Toyama Red Cross Hospital, 11Department of Hematology, Kinki University School of Medicine Nara Hospital, 12Division of Internal Medicine, Toyama City Hospital, 13Department of Hematology, Shizuoka City Shimizu Hospital
International Journal of Myeloma 6 (2) 62-62, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
O-2 IL - 10RB K47E affects the prognosis of multiple myeloma patients treated with thalidomide / bortezomib
Tetsuhiro Kasamatsu1, Rumi Ino1, Yuya Kitamura1, Kazuki Honma1, Tomomi Nagashima1, Nanami Gotoh1, Noriyuki Takahashi1, Morio Matsumoto2, Morio Sawamura2, Hiroshi Handa3, Takayuki Saitoh1, Hirokazu Murakami1
1Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, 2National Hospital Organization, Nishigunma National Hospital, 3Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine
International Journal of Myeloma 6 (2) 63-63, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
O-3 The epigenetic dysregulation of miR - 375 for PDPK1 overexpression / activation in multiple myeloma
Shotaro Tatekawa1, Yoshiaki Chinen1, Yuji Shimura1, Hisao Nagoshi1, Tsutomu Kobayashi1, Yayoi Kimoto1, Eri Kawata2, Tomoko Narita3, Masaki Ri3, Hiroshi Handa4, Nobuhiko Uoshima2, Shinsuke Iida3, Junya Kuroda1
1Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 2Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, 3Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 4Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine
International Journal of Myeloma 6 (2) 64-64, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
O-4 Evaluation of prognostic factor for multiple myeloma patients that received auto-SCT at our hospital
Mitsuhiro Itagaki, Hideki Asaoku, Yuta Katayama, Kayo Toishikawa, Tetsurou Ochi, Ryota Imanaka, Kohei Kyo, Takeshi Okatani, Shinya Katsutani, Koji Iwato, Taiichi Kyo
Department of Hematology, Hiroshima Red Cross Hospital
International Journal of Myeloma 6 (2) 65-65, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
O-5 Double ASCT and maintenance may overcome the adverse cytogenetics in multiple myeloma
Shotaro Hagiwara, Satoru Itoi, Risen Hirai, Akira Tanimura, Tomiteru Togano, Masataka Takeshita, Rieko Sekine, Miki Nakamura, Akiyoshi Miwa
Division of Hematology, Department of Internal Medicine, National Center for Global Health and Medicine
International Journal of Myeloma 6 (2) 66-66, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
O-6 Optimal lenalidomide concentration to predict its toxicity and efficacy in multiple myeloma patients
Yoko Kado1,2, Fumiaki Kitazawa1, Masayuki Tsujimoto3, Shin-ichi Fuchida4, Akira Okano4, Mayumi Hatsuse4, Satoshi Murakami4, Kumi Ueda1, Takatoshi Kokufu1, Akari Kimura3, Takashi Saiki3, Eriko Yuki3, Tetsuya Minegaki3, Kohshi Nishiguchi3, Eishi Ashihara2, Chihiro Shimazaki4
1Department of Pharmacy, Japan Community Health care Organization Kyoto Kuramaguchi Medical Center, 2Department of Clinical and Translational Physiology, Kyoto Pharmaceutical University, 3Department of Clinical Pharmacy, Kyoto Pharmaceutical University, 4Department of Hematology, Japan Community Health care Organization Kyoto Kuramaguchi Medical Center
International Journal of Myeloma 6 (2) 67-67, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
O-7 A phase I / II study of Len and DEX plus CY for the elderly with RRMM : interim report
Yutaka Tsukune1, Yuriko Yahata1, Makoto Sasaki1, Atsushi Isoda2, Jun Ando1, Michiaki Koike3, Norio Komatsu1
1Department of Hematology, Juntendo University School of Medicine, 2Department of Hematology, National Hospital Organization Nishigunma Hospital, 3Department of Hematology, Juntendo University Shizuoka Hospital
International Journal of Myeloma 6 (2) 68-68, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
O-8 Detailed analysis of Ig - light chain in amyloid lesions by mass spectrometry
Toshiya Sugimoto1, Masayoshi Tasaki2,3, Eri Fujii1, Taro Yamashita4, Konen Obayashi2, Shinya Endo5, Nao Nishimura5, Yutaka Okuno5, Shiho Fujiwara5, Naoko Wada5, Hiroaki Mitsuya5, Yukio Ando3, Hiroyuki Hata5,6
1Graduate School of Health Sciences, Kumamoto University, 2Department of Morphological and Physiological Sciences, Kumamoto University, 3Faculty of Life Sciences, Department of Neurology, Kumamoto University, 4Diagnostic Unit for Amyloidosis, Kumamoto University Hospital, 5Faculty of Life Sciences, Department of Hematology, Kumamoto University, 6Division of Informative Clinical Sciences, Kumamoto University
International Journal of Myeloma 6 (2) 69-69, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
O-9 Targeting myeloma progenitors by ex vivo - expanded Th1 - like γδT cells
Hirokazu Miki1, Takeshi Harada2, Shingen Nakamura2, Asuka Oda2, Hikaru Fujino2, Kimiko Sogabe2, Mamiko Takahashi2, Tomoko Maruhashi2, Shiro Fujii2, Hirofumi Tenshin3, Ryota Amachi3, Keiichiro Watanabe3, Jumpei Teramachi4, Kumiko Kagawa2, Masahiro Abe2
1Division of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, 2Department of Hematology, Endocrinology and Metabolism, Tokushima University, 3Department of Orthodontics and Dentofacial Orthopedics, The University of Tokushima Graduate School of Oral Science, 4Department of Histology and Oral Histology, The University of Tokushima Graduate School of Oral Science
International Journal of Myeloma 6 (2) 70-70, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
O-10 Hypoxia - inducible miR - 210 regulates a new myeloma proliferation gene, rRNA methyltransferase DIMT1
Sho Ikeda, Akihiro Kitadate, Takahiro Kobayashi, Fumito Abe, Miho Nara, Atsushi Watanabe, Naoto Takahashi, Hiroyuki Tagawa
Department of Hematology, Nephrology, Rheumatology ,Akita University Graduate School of Medicine
International Journal of Myeloma 6 (2) 71-71, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-1 A comparison of MRD detection among ASO - PCR, dd - PCR and NGS in pts with MM who underwent ASCT
Hiroyuki Takamatsu1, Rachel Wee1, Ryoichi Murata2, Jianbiao Zheng3, Martin Moorhead3, Naoki Takezako4, Shigeki Ito5, Toshihiro Miyamoto6, Kenji Yokoyama7, Kosei Matsue8, Tsutomu Sato9, Toshiro Kurokawa10, Hideo Yagi11, Yasushi Terasaki12, Kinya Ohata1, Takashi Yoshida13, Malek Faham3, Shinji Nakao1
1Department of Hematology, Kanazawa University, 2Division of Internal Medicine, Keiju Kanazawa Hospital, 3Adaptive Biotechnologies Corp, 4Department of Hematology, National Hospital Organization Disaster Medical Center of Japan, 5Department of Medical Oncology, Iwate Medical University School of Medicine, 6Department of Hematology/Oncology, Kyushu University Hospital, 7Department of Hematology/Oncology, Tokai University Hachioji Hospital, 8Department of Hematology/Oncology, Kameda Medical Center, 9Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, 10Department of Hematology, Toyama Red Cross Hospital, 11Department of Hematology, Kinki University School of Medicine Nara Hospital, 12Division of Internal Medicine, Toyama City Hospital, 13Department of Hematology, Shizuoka City Shimizu Hospital
International Journal of Myeloma 6 (2) 74-74, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-2 IL - 10RB K47E affects the prognosis of multiple myeloma patients treated with thalidomide / bortezomib
Tetsuhiro Kasamatsu1, Rumi Ino1, Yuya Kitamura1, Kazuki Honma1, Tomomi Nagashima1, Nanami Gotoh1, Noriyuki Takahashi1, Morio Matsumoto2, Morio Sawamura2, Hiroshi Handa3, Takayuki Saitoh1, Hirokazu Murakami1
1Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, 2National Hospital Organization, Nishigunma National Hospital, 3Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine
International Journal of Myeloma 6 (2) 75-75, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-3 The epigenetic dysregulation of miR - 375 for PDPK1 overexpression / activation in multiple myeloma
Shotaro Tatekawa1, Yoshiaki Chinen1, Yuji Shimura1, Hisao Nagoshi1, Tsutomu Kobayashi1, Yayoi Kimoto1, Eri Kawata2, Tomoko Narita3, Masaki Ri3, Hiroshi Handa4, Nobuhiko Uoshima2, Shinsuke Iida3, Junya Kuroda1
1Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 2Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, 3Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 4Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine
International Journal of Myeloma 6 (2) 76-76, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-4 TNFRSF13 and HMGB1 Up - Regulation in Waldenstrom Macroglobulinemia with Osteolytic Bone Lesion
Naohiro Sekiguchi1, Akihisa Nagata1, Miwa Kurimoto1, Ichiro Fukuda2, Kazuaki Yamada3, Naoki Takezako1
1Hematology Division, National Hospital Organization Disaster Medical Center, 2Radiology Division, National Hospital Organization Disaster Medical Center, 3Laboratory and Pathology Division, National Hospital Organization Disaster Medical Center
International Journal of Myeloma 6 (2) 77-77, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-5 Comprehensive measurement of cytokines / chemokines for analyzing pathogenesis and prognosis in MM
Yukiko Cho1, Katsushige Inada2, Mayuko Koshino2, Yasushi Okoshi2,3, Mitsuo Hori2, Hiroshi Kojima1,3
1Department of Medical Oncology, Ibaraki Prefectural Central Hospital, 2Department of Hematology, Ibaraki Prefectural Central Hospital, 3Ibaraki Clinical Education and Training Center, University of Tsukuba Hospital
International Journal of Myeloma 6 (2) 78-78, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-6 Prognostic Impact of Low Subcutaneous Adipose Tissue on Survival Outcome in Patients with MM
Yasunobu Takeoka1,2, Kazuki Sakatoku2, Akiko Miura2, Ryosuke Yamamura2, Taku Araki2, Hirotaka Seura3, Mitsue Okamur3, Hideo Koh1, Hirohisa Nakamae1, Masayuki Hino1, Kensuke Ohta2
1Department of Hematology, Osaka City University, 2Department of Hematology, Osaka Saiseikai Nakatsu Hospital, 3Department of PET center, Osaka Saiseikai Nakatsu Hospital
International Journal of Myeloma 6 (2) 79-79, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-7 Clinical characteristics of IgD Multiple Myeloma in the era of novel agents
Masahiro Ikeda, Sumito Shingaki, Kanji Miyazaki, Sohsuke Meshitsuka, Yu Abe, Yumiko Yoshiki, Nobuhiro Tsukada, Kenshi Suzuki
Division of Hematology, Japanese Red Cross Medical Center
International Journal of Myeloma 6 (2) 80-80, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-8 Whole body diffusion MRI compared to FDG - PET CT in plasma cell dyscrasia
Kentaro Narita, Manabu Fujisawa, Kota Fukumoto, Yasuhito Suehara, Yoshiaki Usui, Masami Takeuchi, Kosei Matsue
Department of Hematology/Oncology Kameda medical center
International Journal of Myeloma 6 (2) 81-81, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-9 Function of soluble B7 - H1 (PD - L1) and its clinical impact in patients with multiple myeloma
Mika Sunakawa1, Hideto Tamura1, Mariko Ishibashi1, Yoichi Imai2, Hiroshi Handa3, Makoto Sasaki4, Norio Komatsu4, Sakae Tanosaki5, Atsushi Isoda6, Morio Matsumoto6, Shigeki Ito7, Yoji Ishida8, Michiaki Koike9, Koiti Inokuchi1
1Division of Hematology, Department of Medicine, Nippon Medical School, 2Department of Hematology, Tokyo Women's Medical University, 3Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine, 4Division of Hematology, Department of Internal Medicine, Juntendo University School of Medicine, 5Department of Hematology, Fraternity Memorial Hospital, 6Department of Hematology, National Hospital Organization Nishigunma National Hospital, 7Department of Medical Oncology, Iwate Medical University School of Medicine, 8Division of Hematology and Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, 9Department of Hematology, Juntendo University Shizuoka Hospital
International Journal of Myeloma 6 (2) 82-82, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-10 Significance of serum thymidine kinase activity in patients with newly diagnosed multiple myeloma
Kazuhito Suzuki1, Shingo Yanno1, Takaki Shimada1, Yuichi Yahagi1, Katsuki Sugiyama1, Yoji Ogasawara1, Shinobu Takahara1, Takeshi Saito1, Jiro Minami1, Hiroki Yokoyama1, Yutaro Kamiyama1, Atsushi Katsube1, Hideki Uryu1, Noriko Usui2, Keisuke Aiba1
1the Jikei University School of Medicine, 2the Jikei Daisan Hospital
International Journal of Myeloma 6 (2) 83-83, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-11 CD138 immunostaining of BM biopsy / clot should be performed for quantification of plasma cells
Kaori Kumata1, Yoshiaki Usui2, Kentarou Narita2, Masami Takeuchi2, Kousei Matsue2
1Department of Pathology, Kameda Medical Center, 2Division of Hematology/Oncology, Kameda Medikal Center
International Journal of Myeloma 6 (2) 84-84, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-12 Expression profiles of natural killer cell ligands in heterogenous myeloma subpopulations
Makoto Yawata1,2, Sarah Siti Daud1, Zhe Shao2, Gopalakrishnan Sathish3, Kiat Hoe Ong4, Nobuyo Yawata2,5, Wee Joo Chng6
1School of Medicine, National University of Singapore and National University Health System, Singapore Department of Pediatrics, 2Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, 3Department of Haematology, Singapore General Hospital, 4Department of Haematology, Tan Tock Seng Hospital, 5Singapore Eye Research Institute, and Duke-National University of Singapore Graduate Medical School, 6Department of Haematology-Oncology, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System
International Journal of Myeloma 6 (2) 85-85, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-13 Clinicopathological study of kidney disease associated with plasma cell dyscrasias
Yoshiaki Usui1, Manabu Fujisawa1, Kentaro Narita1, Kota Fukumoto1, Yasuhito Suehara1, Masami Takeuchi1, Michihiro Mitobe2, Kosei Matsue1
1Department of Hematology/Oncology, Kameda Medical Center, 2Department of Nephrology, Kameda Medical Center
International Journal of Myeloma 6 (2) 86-86, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-14 A KL - 6 - producing myeloma patient with leukemia transformation and clinical significance of KL - 6
Akiko Yamada1, Hideto Tamura1, Mariko Ishibashi1, Makoto Sasaki2, Yoichi Imai3, Hiroshi Handa4, Sakae Tanosaki5, Shigeki Ito6, Yoji Ishida7, Atsushi Isoda8, Morio Matsumoto8, Michiaki Koike9, Norio Komatsu2, Koiti Inokuchi1
1Division of Hematology, Department of Medicine, Nippon Medical School, 2Division of Hematology, Department of Internal Medicine, Juntendo University School of Medicine, 3Department of Hematology, Tokyo Women's Medical University, 4Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine, 5Department of Hematology, Fraternity Memorial Hospital, 6Department of Medical Oncology, Iwate Medical University School of Medicine, 7Division of Hematology and Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, 8Department of Hematology, National Hospital Organization Nishigunma National Hospital, 9Department of Hematology, Juntendo University Shizuoka Hospital
International Journal of Myeloma 6 (2) 87-87, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-16 Multiple myeloma with myelofibrosis
Koiso Hiromi1,2, Makiko Takizawa2, Akihiko Yokohama3, Takayuki Saitoh6, Hiroshi Handa2, Norifumi Tsukamoto4, Masami Murakami5, Hirokazu Murakami6
1Infection Control and Prevention Center, Gunma University Hospital, 2Medical and Clinical Science, Gunma University Graduate School of medicine, 3Blood Ttansfusion Service, Gunma Universyt, 4Oncology Center, Gunma University Hospital, 5Department of Clinical Laboratory Medicine, Gunma University Graduate School of medicine, 6Schooi of Health Science, Faculty of Medicine, Gunma University
International Journal of Myeloma 6 (2) 88-88, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-17 Russell bodies and needle - shaped inclusions in multiple myeloma complicated with MDS
Toshiki Yamada1, Yasuhito Nannya2, Hisashi Tsurumi2
1Department of Hematology, Gifu Prefectural General Medical Center, 2Department of Hematology, Gifu Univ. Sch. Med
International Journal of Myeloma 6 (2) 89-89, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-18 Pim - 2 is a critical downstream mediator of RANKL for osteoclastogenesis enhanced in myeloma
Jumpei Teramachi1,2, Masahiro Hiasa1,3, Asuka Oda1, Takeshi Harada1, Hirofumi Tenshin1,4, Shingen Nakamura1, Ryota Amachi1,4, Shiro Fujii1, Keiichirou Watanabe1,4, Kumiko Kagawa1, Hirokazu Miki5, Itsuro Endo1, Tatsuji Haneji2, Toshio Matsumoto6, Masahiro Abe1
1Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School, 2Department of Histology and Oral histology, Tokushima University Graduate School, 3Department of Biomaterials and Bioengineering, Tokushima University Graduate School, 4Department of Orthodontics and Dentofacial Orthopedics, Tokushima University Graduate School, 5Division of Transfusion and Cell Therapy Medicine, Tokushima University Hospital, 6Fujii Memorial Institute of Medical Sciences, Tokushima University
International Journal of Myeloma 6 (2) 90-90, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-19 Correlation between prognosis and morphological abnormalities in multiple myeloma
Shun Iida, Shotaro Hagiwara, Akiyoshi Miwa
Division of Hematology, National Center for Global Health and Medicine
International Journal of Myeloma 6 (2) 91-91, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-20 Clinical aspects in biclonal gammopathies
Yuichi Nakamura, Yuu Akuzawa, Yoshihiro Ito, Naoki Wakimoto, Emi Kakegawa, Yumiko Uchida, Shigehisa Mori, Masami Bessho
Department of Hematology, Saitama Medical University Hospital
International Journal of Myeloma 6 (2) 92-92, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-21 Optimal lenalidomide concentration to predict its toxicity and efficacy in multiple myeloma patients
Yoko Kado1,2, Fumiaki Kitazawa1, Masayuki Tsujimoto3, Shin-ichi Fuchida4, Akira Okano4, Mayumi Hatsuse4, Satoshi Murakami4, Kumi Ueda1, Takatoshi Kokufu1, Akari Kimura3, Takashi Saiki3, Eriko Yuki3, Tetsuya Minegaki3, Kohshi Nishiguchi3, Eishi Ashihara2, Chihiro Shimazaki4
1Department of Pharmacy, Japan Community Health care Organization Kyoto Kuramaguchi Medical Center, 2Department of Clinical and Translational Physiology, Kyoto Pharmaceutical University, 3Department of Clinical Pharmacy, Kyoto Pharmaceutical University, 4Department of Hematology, Japan Community Health care Organization Kyoto Kuramaguchi Medical Center
International Journal of Myeloma 6 (2) 93-93, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-22 A case of multiple myeloma, PR was maintained with alternate - day 1 mg pomalidomide
Mutsumi Wakabayashi1, Yasunobu Seiguchi1, Haruko Takizawa1, Keiji Sugimoto1, Hiroshi Izumi2, Shigeki Tomita2, Norio Komatsu3, Masaaki Noguchi1
1Department of Hematology, Juntendo University Urayasu Hospital, 2Department of Pathology, Juntendo University Urayasu Hospital, 3Department of Hematology, Juntendo University Hospital
International Journal of Myeloma 6 (2) 94-94, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-23 Safety and efficiency of PETHEMA - like VMP with subcutaneous - bortezomib administration
Satoru Kosugi1, Masashi Nakagawa2, Jun Ishiko2, Toru Kida1, Norimitsu Saito3, Hideki Mitsui3, Yasuhiro Moriyama4, Nobuhiko Tominaga5, Seiji Tadokoro6, Tetsuo Maeda6, Hitoshi Yoshida7, Hiroyuki Sugahara8, Yuzuru Kanakura6, Shuichi Katagiri1
1Department of Internal Medicine (Hematology), Toyonaka Municipal Hospital, 2Department of Hematology and Cancer Chemotherapy, Nissei Hospital, 3Department of Hematology, Otemae Hospital, 4Department of Hematology, Ikeda Municipal Hospital, 5Department of Hematology, Suita Municipal Hospital, 6Department of Hematology and Oncology, Osaka University Graduate School of Medicine, 7Department of Hematology and Cancer Chemotherapy, Osaka Medical Center for Cancer and Cardiovascular Diseases, 8Department of Hematology, Sumitomo Hospital
International Journal of Myeloma 6 (2) 95-95, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-24 Lenalidomide (Len) in patients with plasma cell disorder and hemodialysis (HD)
Mitsufumi Nishio1, Miho Yoshida1, Seiji Hashimoto2, Tomochika Maoka2, Rie Yamamoto2, Nobuhiko Okamoto2
1Department of Hematology and Oncology, NTT East Japan Hospital, 2Department of Nephrology, NTT East Japan Sapporo Hospital
International Journal of Myeloma 6 (2) 96-96, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-25 Retrospective analysis of pomalidomide plus low - dose dexamethasone (Pom / dex) therapy
Shiori Kinoshita, Masaki Ri, Chie Katou, Takahiro Nakashima, Shinya Hagiwara, Takashi Kanamori, Satsuki Murakami, Haruhito Totani, Takashi Yoshida, Tomoko Narita, Asahi Ito, Shigeru Kusumoto, Takashi Ishida, Hirokazu Komatsu, Shinsuke Iida
Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences
International Journal of Myeloma 6 (2) 97-97, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-26 The efficacy of pomalidomide, cyclophosphamide, and dexamethasone for relapsed / refractory myeloma
Yasuyuki Nagata, Shinichiro Oka, Miwa Adachi, Yusuke Fukatsu, Tomohiro Yagyu, Takaaki Ono
Division of Hematology, Internal Medicine 3, Hamamatsu University School of Medicine
International Journal of Myeloma 6 (2) 98-98, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-27 Pd - therapy against relapse and refractory multiple myeloma patients in our institute
Masao Hagihara, Morihiro Inoue, Jian Hua, Tomoyuki Uchida
Department of Hematology, Eiju General Hospital
International Journal of Myeloma 6 (2) 99-99, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-28 Evaluation of prognostic factor for multiple myeloma patients that received auto - SCT at our hospital
Mitsuhiro Itagaki, Hideki Asaoku, Yuta Katayama, Kayo Toishikawa, Tetsurou Ochi, Ryota Imanaka, Kohei Kyo, Takeshi Okatani, Shinya Katsutani, Koji Iwato, Taiichi Kyo
Department of Hematology, Hiroshima Red Cross Hospital
International Journal of Myeloma 6 (2) 100-100, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-29 Dose reduction and escalation regimen for panobinostat in patients with refractory multiple myeloma
Tetsuya Ishikawa1, Yuri Miyazawa1, Atsushi Isoda1, Morio Matsumoto1, Morio Sawamura2
1Department of Hematology, National Hospital Organization Nishigunma Hospital, 2Department of Clinical Research, National Hospital Organization Nishigunma Hospital
International Journal of Myeloma 6 (2) 101-101, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-30 Results of treatment for newly diagnosed symptomatic multiple myeloma
Masayuki Matsuda, Tatsunori Ishikawa, Masaaki Nishinohara, Shiro Kubonishi, Masanori Makita, Kazutaka Sunami
Department of Hematology, National Hospital Organization Okayama Medical Center
International Journal of Myeloma 6 (2) 102-102, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-31 Successful treatment of lenalidmide for central nervous system relapse in plasma cell leukemia
Ayumi Fujimoto, Nobuhiro Hiramoto, Yoshimitsu Shimomura, Noboru Yonetani, Takayuki Ishikawa
Department of Hematology, Kobe City Medical Center General Hospital
International Journal of Myeloma 6 (2) 103-103, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-32 DCEP is an effective regimen for relapsed refractory multiple myeloma in the era of novel agents
Shin-ichi Fuchida, Akira Okano, Mayumi Hatsuse, Satoshi Murakami, Chihiro Shimazaki
Department of Hematology, JCHO Kyoto Kuramaguchi Medical Center
International Journal of Myeloma 6 (2) 104-104, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-33 A phase I / II study of Len and DEX plus CY for the elderly with RRMM : interim report
Yutaka Tsukune1, Yuriko Yahata1, Makoto Sasaki1, Atsushi Isoda2, Jun Ando1, Michiaki Koike3, Norio Komatsu1
1Department of Hematology, Juntendo University School of Medicine, 2Department of Hematology, National Hospital Organization Nishigunma Hospital, 3Department of Hematology, Juntendo University Shizuoka Hospital
International Journal of Myeloma 6 (2) 105-105, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-34 Efficary of induction (BD) , SCH (CY + G - CSF) , SCT, consolidation (VRD) and maintenance thepary in young NDMM
Akira Tanimura, Risen Hirai, Tomiteru Togano, Masataka Takeshita, Rieko Sekine, Shotaro Hagiwara, Akiyoshi Miwa
National Center for Global Health and Medicine
International Journal of Myeloma 6 (2) 106-106, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-35 The efficacy of maintenance therapy for transplant eligible patients with myeloma
Tomiteru Togano, Satoru Itoi, Rieko Sekine, Risen Hirai, Akira Tanimura, Masataka Takeshita, Shotarou Hagiwara, Akiyoshi Miwa
Dep. of hematology, National center for global health and medicine
International Journal of Myeloma 6 (2) 107-107, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-36 A retrospective analysis of elderly patients with multiple myeloma : Miyazaki cofort
Hitoshi Matsuoka1,8, Hiroshi Kawano1,8, Yoko Kubuki2,8, Kiyoshi Yamashita3,8, Takanori Toyama4,8, Koichi Maeda5,8, Siichi Sato6,8, Junzou Ishizaki7,8, Akira Kitanaka2,8, Kazuya Shimoda2,8
1Department of Internal medicine, Koga General Hospital, 2Dept. of Gastroenteroogy and Hematology Faculty of Medicine, University of Miyazaki, 3Dept. of Internal medicine, Miyazaki prefectural hospital, 4Dept. of Internal medicine, Nobeoka prefectural hospital, 5Dept. of Internal medicine, National Miyakonojo medical center, 6Dept. of Internal medicine, Fujimoto General Hospital, 7Dept. of Internal medicine, Syunkoukai Nichinan Hospital, 8Miyazaki hemotology group
International Journal of Myeloma 6 (2) 108-108, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-37 Double ASCT and maintenance may overcome the adverse cytogenetics in multiple myeloma
Shotaro Hagiwara, Satoru Itoi, Risen Hirai, Akira Tanimura, Tomiteru Togano, Masataka Takeshita, Rieko Sekine, Miki Nakamura, Akiyoshi Miwa
Division of Hematology, Department of Internal Medicine, National Center for Global Health and Medicine
International Journal of Myeloma 6 (2) 109-109, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-38 VGPR induced by continuing bortezomib therapy in a transplant - ineligible patient with IgM myeloma
Shinya Okuda, Chiaki Takebayashi, Koichi Sugimoto
Department of hematology and oncology, JR Tokyo general hospital
International Journal of Myeloma 6 (2) 110-110, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-39 The efficacy of melpharan plus bortezomib followed by PBSCT in elderly multiple myeloma patients
Naoki Takezako, Yuuya Kurihara, Kenichi Itou, Miwa Kurimoto, Naohiro Sekiguchi
Department of Hematology, Disaster Medical Center
International Journal of Myeloma 6 (2) 111-111, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-40 A case series of 15 IgD myeloma patients. Impact of re - transplantation after relapse
Masataka Takeshita, Risen Hirai, Akira Tanimura, Tomiteru Togano, Rieko Sekine, Satoru Itoi, Shotaro Hagiwara, Akiyoshi Miwa
National Center for Global Health and Medicine
International Journal of Myeloma 6 (2) 112-112, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-41 Preference usage of certain V regions in AL amyloidosis patients
Nao Nishimura1, Shinya Endo1, Eri Fujii2, Niina Ueno1, Hiroyuki Hata1,2, Hiroaki Mitsuya1, Yutaka Okuno1
1Department of Hematology,Kumamoto University School of Medicine, 2department of Immunology and Hematology,Kumamoto University School of Health Sciences
International Journal of Myeloma 6 (2) 113-113, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-42 Detailed analysis of Ig - light chain in amyloid lesions by mass spectrometry
Toshiya Sugimoto1, Masayoshi Tasaki2,3, Eri Fujii1, Taro Yamashita4, Konen Obayashi2, Shinya Endo5, Nao Nishimura5, Yutaka Okuno5, Shiho Fujiwara5, Naoko Wada5, Hiroaki Mitsuya5, Yukio Ando3, Hiroyuki Hata5,6
1Graduate School of Health Sciences, Kumamoto University, 2Department of Morphological and Physiological Sciences, Kumamoto University, 3Faculty of Life Sciences, Department of Neurology, Kumamoto University, 4Diagnostic Unit for Amyloidosis, Kumamoto University Hospital, 5Faculty of Life Sciences, Department of Hematology, Kumamoto University, 6Division of Informative Clinical Sciences, Kumamoto University
International Journal of Myeloma 6 (2) 114-114, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-43 Impact of lenalidomide / low - dose dexamethasone therapy on the action of warfarin in AL amyloidosis
Fumiaki Kitazawa1, Shin-ichi Fuchida2, Fumitaka Ise1, Yoko Kado1, Kumi Ueda1, Takatoshi Kokufu1, Akira Okano2, Mayumi Hatsuse2, Satoshi Murakami2, Yuko Nakayama3, Kohji Takara3, Chihiro Shimazaki2
1Department of Pharmacy, Japan Community Health care Organization Kyoto Kuramaguchi Medical Center, 2Department of Hematology, Japan Community Health care Organization Kyoto Kuramaguchi Medical Center, 3Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Himeji Dokkyo University
International Journal of Myeloma 6 (2) 115-115, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-44 A retrospective analysis of 44 patients with systemic AL amyloidosis at our institution
Kazuya Ishiguro1, Toshiaki Hayashi2, Yoshihiro Yokoyama1, Yuka Aoki1, Hiroshi Ikeda1, Tadao Ishida1
1Department of Gastroenterology, Rheumatology, and Clinical Immunology, Sapporo Medical University School of Medicine, 2Department of Hematology, Teine Keijinkai Hospital
International Journal of Myeloma 6 (2) 116-116, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-45 The optimal timing of bortezomib administration for hematopoietic stem cell collection
Taichi Matsumoto1, Yasushi Takamatsu2, Shiro Jimi3, Masahiko Kimura1, Keisuke Migita1, Shuuji Hara1
1Department of Drug Informatics, Faculty of Pharmaceutical Sciences, Fukuoka University, 2Division of Medical Oncology, Hematology and Infectious Disease, Faculty of Medicine, Fukuoka University, 3Central Laboratory of Pathology and Morphology, Faculty of Medicine, Fukuoka University
International Journal of Myeloma 6 (2) 117-117, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-46 IgA - type Schnitzler's syndrome with chromosomal translocation t (4 ; 14)
Tsutomu Kobayashi, Yoshimi Mizuno, Yoshiaki Chinen, Shinsuke Mizutani, Hisao Nagoshi, Yuji Shimura, Mio Sugitani, Shigeo Horiike, Junya Kuroda
Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine
International Journal of Myeloma 6 (2) 118-118, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-47 Expression levels of NCAM are associated with sensitivity to bortezomib in multiple myeloma (MM)
Takashi Yoshida, Masaki Ri, Shiori Kinoshita, Tomoko Narita, Asahi Ito, Shigeru Kusumoto, Takashi Ishida, Hirokazu Komatsu, Shinsuke Iida
Department of Hematology & Oncology, Nagoya City University Graduate School of Medical Sciences
International Journal of Myeloma 6 (2) 119-119, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-48 A case of multiple solitary plasmacytoma successfully treated with VMP therapy in young patient
Katsura Furukawa, Atsushi Murase, Naoto Imoto, Masaya Hayakawa, Hiroshi Kosugi
Department of Hematology
International Journal of Myeloma 6 (2) 120-120, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-49 Combination of lenalidomide and zoledronic acid revitalized human gdT cells' anti - myeloma activity
Qu Cui1,2, Shingen Nakamura2, Hirokazu Miki3, Ayako Nakano4, Takeshi Harada2, Shiro Fujii2, Kumiko Kagawa2, Shuji Ozaki5, Yuanbo Liu1, Hiayu Qi6, Toshio Matsumoto7, Masahiro Abe2
1Department of Hematology, Beijing Tiantan Hospital, Capital Medical University, 2Department of Hematology, Endocrinology and Metabolism, Tokushima University, 3Division of Transfusion Medicine and Cell Therapy, Tokushima Universiry Hospital, 4Division of Internal Medicine, Tokushima Prefecture Naruto Hospital, 5Division of Hematology, Tokushima Prefectural Central Hospital, 6Department of Rheumatology, Beijing Friendship Hospital, Capital Medical University, 7Fujii Memorial Institute of Medical Sciences, Tokushihma University
International Journal of Myeloma 6 (2) 121-121, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-50 Extramedullary plasmacytoma in the stomach in 3 patients with MM and review of literature
Yasuko Hamada1,2, Taro Mizuki1, Jyun Sasaki3, Norio Komatsu3, Hiroshi Handa4, Hideto Tamura2, Sakae Tanosaki1
1Division of Hematology, the Fraternity Memorial Hospital, 2Division of Hematology, Department of Medicine, Nippon Medical School, 3Division of Hematology, Juntendou University School of Medicine, 4Division of Hematology, Gunma University
International Journal of Myeloma 6 (2) 122-122, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-51 Targeting myeloma progenitors by ex vivo - expanded Th1 - like γδ T cells
Hirokazu Miki1, Takeshi Harada2, Shingen Nakamura2, Asuka Oda2, Hikaru Fujino2, Kimiko Sogabe2, Mamiko Takahashi2, Tomoko Maruhashi2, Shiro Fujii2, Hirofumi Tenshin3, Ryota Amachi3, Keiichiro Watanabe3, Jumpei Teramachi4, Kumiko Kagawa2, Masahiro Abe2
1Division of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, 2Department of Hematology, Endocrinology and Metabolism, Tokushima University, 3Department of Orthodontics and Dentofacial Orthopedics, The University of Tokushima Graduate School of Oral Science, 4Department of Histology and Oral Histology, The University of Tokushima Graduate School of Oral Science
International Journal of Myeloma 6 (2) 123-123, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-52 Hypoxia - inducible miR - 210 regulates a new myeloma proliferation gene, rRNA methyltransferase DIMT1
Sho Ikeda, Akihiro Kitadate, Takahiro Kobayashi, Fumito Abe, Miho Nara, Atsushi Watanabe, Naoto Takahashi, Hiroyuki Tagawa
Department of Hematology, Nephrology, Rheumatology , Akita University Graduate School of Medicine
International Journal of Myeloma 6 (2) 124-124, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-53 IL - 34 promotes osteoclast formation and enhances osteolytic disease in multiple myeloma
Muhammad Baghdadi, Sayaka Nakanishi, Haruka Wada, Ken-ichiro Seino
Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University
International Journal of Myeloma 6 (2) 125-125, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-54 Dual inhibition of EZH2 and EZH1 sensitizes myeloma cells to bortezomib
Ola Rizq1, Tohru Iseki3, Chiaki Nakaseko2, Atsushi Iwama1, Naoya Mimra3
1Department of Cellular and Molecular Medicine, Chiba University Graduate School of Medicine, 2Department of Hematology, Chiba University Hospital, 3Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital
International Journal of Myeloma 6 (2) 126-126, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-55 11 Newly diagnosed Multiple myeloma patients analyzed by Targeted semiconductor sequencing
Hiroshi Ikeda, Kazuya Ishiguro, Yuka Aoki, Tadao Ishida
Department of gastroentology and clinical imunology Sapporo Medical University
International Journal of Myeloma 6 (2) 127-127, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-56 Development of thiazolidine-2,4-dione - family compounds with a unique anti - myeloma activity
Shiro Fujii1, Hirokazu Miki2, Ariunzaya Bat-Erdene1, Kimiko Sogabe1, Hikaru Fujino1, Tomoko Maruhashi1, Shingen Nakamura1, Kumiko Kagawa1, Ryota Amachi3, Hirofumi Tenshin3, Jumpei Teramachi4, Masahiro Abe1
1Department of Hematology, Endocrinology and Metabolism, Tokushima University, 2Division of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, 3Department of Orthodontics and Dentofacial Orthopedics, Tokushima University, 4Department of Histology and Oral Histology, Tokushima University
International Journal of Myeloma 6 (2) 128-128, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-57 Bufalin induces apoptosis in myeloma cells through DNA damage at hypoxic conditions
Eri Fujii1,2, Nao Nishimura3, Shinya Endo3, Naoko Wada3, Shiho Fujiwara3, Yoshitaka Kikukawa3, Hiroaki Mitsuya3, Yutaka Okuno3, Hiroyuki Hata3,4
1Graduate School of Health Sciences, Kumamoto University, 2Laboratory for Clinical Investigation, Osaka University Hospital, 3Faculty of Life Sciences, Department of Hematology, Kumamoto University, 4Division of Informative Clinical Sciences, Kumamoto University
International Journal of Myeloma 6 (2) 129-129, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-58 Clinical significance of serum soluble SLAMF7 in multiple myeloma
Saori Soeda1, Hideto Tamura1, Mariko Ishibashi1, Atsushi Isoda2, Morio Matsumoto2, Makoto Sasaki3, Norio Komatsu3, Hiroshi Handa4, Yoichi Imai5, Sakae Tanosaki6, Shigeki Ito7, Yoji Ishida8, Michiaki Koike9, Koiti Inokuchi1
1Division of Hematology, Department of Medicine, Nippon Medical School, 2Department of Hematology, National Hospital Organization Nishigunma National Hospital, 3Division of Hematology, Department of Internal Medicine, Juntendo University School of Medicine, 4Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine, 5Department of Hematology, Tokyo Women's Medical University, 6Department of Hematology, Fraternity Memorial Hospital, 7Department of Medical Oncology, Iwate Medical University School of Medicine, 8Division of Hematology and Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, 9Department of Hematology, Juntendo University Shizuoka Hospital
International Journal of Myeloma 6 (2) 130-130, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-59 TRAIL induces osteoclast activation and survival via TAK1
Hirofumi Tenshin1,3, Jumpei Teramachi3,4, Asuka Oda3, Ryota Amachi2,3, Masahiro Hiasa3,5, Keiichiro Watanabe2,3, Shingen Nakamura3, Hirokazu Miki6, Itsuro Endo3, Eiji Tanaka2, Toshio Matsumoto7, Masahiro Abe3
1Department of Orthodontics and Dentofacial Orthopedics, Graduate School of Oral Science, The University of Tokushima, 2Department of Orthodontics and Dentofacial Orthopedics, Institute of Biomedical Sciences, Tokushima University Graduate School, 3Department of Hematology, Endocrinology and Metabolism, Institute of Biomedical Sciences, Tokushima University Graduate School, 4Department of Histology and Oral Histology, Institute of Biomedical Sciences, Tokushima University Graduate School, 5Department of Biomaterials and Bioengineering, Institute of Biomedical Sciences, Tokushima University Graduate School, 6Division of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, 7Fujii Memorial Institute of Medical Sciences, Tokushima University
International Journal of Myeloma 6 (2) 131-131, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-60 Anti - proliferative effect of YM155 via suppression of c - Myc expression on myeloma cells
Maki Asahi1, Motoki Takano1, Shigeki Ito2, Yoji Ishida1
1Hematology and Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, 2Department of Medical Oncology, Iwate Medical University School of Medicine
International Journal of Myeloma 6 (2) 132-132, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-61 Drug Design and Characterization of Anti - Myeloma Effects Using Novel Komaroviquinone Derivatives
Mariko Sato1, Shotaro Kitabatake1, Kota Fujimori1, Daiju Ichikawa1, Yutaka Suto2, Genji Iwasaki2, Fumiyuki Kiuchi3, Takashi Yamaguchi1, Arimi Ueda1, Shuji Aida1, Maiko Matsushita1, Yutaka Hattori1
1Clinical Physiology & Therapeutics, Keio University Faculty of Pharmacy, 2Synthesic Organic Chemistry Laboratory, Takasaki University oh Health and Welfare Faculty of Pharmacy, 3Natural Medicines, Keio University Faculty of Pharmacy
International Journal of Myeloma 6 (2) 133-133, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
P-62 Targeting Sp1, a critical mediator for myeloma growth and survival, by panobinostat
Bat-Erdene Ariunzaya1, Shingen Nakamura1, Kumiko Kagawa1, Shiro Fujii1, Kimiko Sogabe1, Ryota Amachi1,2, Asuka Oda1, Hirofumi Tenshin1,2, Takeshi Harada1, Jumpei Teramachi1,3, Hirokazu Miki1,4, Toshio Matsumoto1,5, Masahiro Abe1

International Journal of Myeloma 6 (2) 134-134, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
New standards of care for NDMM 〜 Patients not eligible for transplant 〜
Dr. Sadd Z. Usmani
Director of Plasma Cell Disorders program Director of Clinical Research in Hematologic Malignancies Levine Cancer Institute/Carolinas Healthcare System
International Journal of Myeloma 6 (2) 136-136, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
New Drugs and New Targets in Multiple Myeloma (MM)
Andrew Spencer, DM, FRACP, FRCPA
Department of Clinical Haematology, Alfred Hospital, Monash University
International Journal of Myeloma 6 (2) 137-137, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
Function of NK cells in Multiple Myeloma
Shiotaro Hagiwara
Div. Hematology, Internal Medicine, National Center for Global Health and Medicine
International Journal of Myeloma 6 (2) 138-138, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
Immunotherapy in multiple myeloma
Hiroyoshi Nishikawa
Division of Cancer Immunology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center
International Journal of Myeloma 6 (2) 139-139, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
Regulating mechanism of myeloma cell growth and survival in the bone marrow niche
Teru Hideshima
Dana-Farber Cancer Institute and Harvard Medical School
International Journal of Myeloma 6 (2) 140-140, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
Histone deacetylases as therapeutic targets for multiple myeloma
Yusuke Furukawa
Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University
International Journal of Myeloma 6 (2) 141-141, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
Clinical utility of panobinostat in the treatment of multiple myeloma
Chihiro Shimazaki
Department of Hematology, Japan Community Health care Organization Kyoto Kuramaguchi Medical Center
International Journal of Myeloma 6 (2) 142-142, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。
Recent Advance in the Treatment of High - Risk Multiple Myeloma
Tadao Ishida
Department of Hematology, Japanese Red Cross Medical Center
International Journal of Myeloma 6 (2) 143-143, 2016.
  • 全文ダウンロード: 従量制、基本料金制の方共に121円(税込) です。